AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • December 23rd, 2020 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT (the “Second Amendment”) is dated as of December 21, 2020 (the “Second Amendment Date”) and is entered into by and among X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and each of its Qualified Subsidiaries, including without limitation X4 THERAPEUTICS, INC. (“Therapeutics”) (hereinafter collectively referred to as the “Borrower”), the several banks and other financial institutions or entities from time to time parties hereto (collectively, referred to as “Lender”) and HERCULES CAPITAL, INC., a Maryland corporation, in its capacity as administrative agent for itself and the Lender (in such capacity, the “Agent”). Capitalized terms used herein without definition shall have the same meanings given them in the Agreement (as defined below).
